Jacobio Completes First Patient Dosage of CD73 mAb JAB-BX102 in China

Retrieved on: 2022-09-02 11:10:11

Tags for this article:

Click the tags to see associated articles and topics

Jacobio Completes First Patient Dosage of CD73 mAb JAB-BX102 in China. View article details on hiswai:

Excerpt

JAB-BX102 is a humanized monoclonal antibody, anti-CD73. ... There are no anti-CD73 antibodies currently approved for cancer therapy.

Article found on: www.citizentribune.com